Basel Medical Group Ltd
NASDAQ:BMGL
Cash Flow Statement
Cash Flow Statement
Basel Medical Group Ltd
| Jun-2024 | Dec-2024 | Jun-2025 | ||
|---|---|---|---|---|
| Operating Cash Flow | ||||
| Net Income |
2
|
0
|
(13)
|
|
| Depreciation & Amortization |
1
|
1
|
1
|
|
| Other Non-Cash Items |
0
|
0
|
11
|
|
| Cash Taxes Paid |
0
|
0
|
0
|
|
| Cash Interest Paid |
0
|
0
|
1
|
|
| Change in Working Capital |
(1)
|
(2)
|
(4)
|
|
| Cash from Operating Activities |
3
N/A
|
(1)
N/A
|
(4)
-205%
|
|
| Investing Cash Flow | ||||
| Capital Expenditures |
(0)
|
(0)
|
(0)
|
|
| Other Items |
0
|
0
|
(11)
|
|
| Cash from Investing Activities |
(0)
N/A
|
0
N/A
|
(11)
N/A
|
|
| Financing Cash Flow | ||||
| Net Issuance of Common Stock |
0
|
0
|
10
|
|
| Net Issuance of Debt |
(3)
|
(3)
|
5
|
|
| Other |
1
|
11
|
2
|
|
| Cash from Financing Activities |
(2)
N/A
|
8
N/A
|
17
+114%
|
|
| Change in Cash | ||||
| Effect of Foreign Exchange Rates |
0
|
(0)
|
(0)
|
|
| Net Change in Cash |
1
N/A
|
7
+786%
|
1
-84%
|
|
| Free Cash Flow | ||||
| Free Cash Flow |
3
N/A
|
(1)
N/A
|
(4)
-205%
|
|